Publications (325) Publications de EMILIA CERCENADO MANSILLA

2024

  1. Activity of cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations on Enterobacter cloacae complex and Klebsiella aerogenes in Spain (SMART 2016-2022)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

  2. Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)

    Infectious Diseases, Vol. 56, Núm. 6, pp. 441-450

  4. Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803

  5. Characterizing carbapenemase-producing Escherichia coli isolates from Spain: high genetic heterogeneity and wide geographical spread

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  6. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

    mSphere, Vol. 9, Núm. 3

  7. Corrigendum: Tranexamic acid in combination with vancomycin or gentamicin has a synergistic effect against staphylococci (Front. Microbiol., (2023), 13, 935646, 10.3389/fmicb.2022.935646)

    Frontiers in Microbiology

  8. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

  9. Invasive disease caused simultaneously by two different serotypes of Streptococcus pneumoniae: a microbiological appreciation

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 5, pp. 1013-1016

  10. Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality

    Journal of Hospital Infection, Vol. 149, pp. 56-64

  11. Validation of the antibacterial effect of topically applied tranexamic acid using in vitro and in vivo models

    Frontiers in Microbiology, Vol. 15

2023

  1. A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis

    Antibiotics, Vol. 12, Núm. 3

  2. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  3. Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 3, pp. 302-309

  4. An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004–2020)

    Frontiers in Microbiology, Vol. 14

  5. Antibiotic resistance in bloodstream isolates from high-complexity paediatric units in Madrid, Spain: 2013–2021

    Journal of Hospital Infection, Vol. 139, pp. 33-43

  6. Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 238-242

  7. Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms

    Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922

  8. Automatic antibiotic resistance prediction in Klebsiella pneumoniae based on MALDI-TOF mass spectra

    Engineering Applications of Artificial Intelligence, Vol. 118

  9. Carbapenemase-Producing Klebsiella pneumoniae in COVID-19 Intensive Care Patients: Identification of IncL-VIM-1 Plasmid in Previously Non-Predominant Sequence Types

    Antibiotics, Vol. 12, Núm. 1